Johnson & Johnson Share Holder Equity 2010-2024 | JNJ

Johnson & Johnson share holder equity for the quarter ending September 30, 2024 was $70.158B, a 1.5% decline year-over-year.

  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
  • Johnson & Johnson share holder equity for 2021 was $74.023B, a 16.98% increase from 2020.

Johnson & Johnson Share Holder Equity 2010-2024 | JNJ

  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
  • Johnson & Johnson share holder equity for 2021 was $74.023B, a 16.98% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$765.2B
Novo Nordisk (NVO)$494.2B
AbbVie (ABBV)$356.4B
Merck (MRK)$257.5B
Novartis AG (NVS)$223.6B
AstraZeneca (AZN)$205.5B
Pfizer (PFE)$158.6B
Sanofi (SNY)$134.1B
Innoviva (INVA)$1.2B